Juan Pablo Cruz

Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms.

Acute and subacute complications from the use of the Pipeline device are becoming evident. Here, the authors report delayed ipsilateral hemorrhage in 8.5% of patients with anterior circulation aneurysms treated with this device. All bleeds were distant from the treated aneurysms. All procedures were done without complications and when waking after the embolization all patients were normal. Despite this, hemorrhages occurred 1–6 days postprocedure, and were not related to aneurysm size, intraprocedural complications, or anticoagulation. BACKGROUND AND PURPOSE: The PED is a flow-diverting stent designed for the treatment of cerebral aneurysms. We report 4 cases of delayed ipsilateral IPH following the technically successful treatment of anterior circulation aneurysms with the PED. MATERIALS AND METHODS: Clinical and imaging data from all patients undergoing aneurysm treatment with the PED at 2 institutions were analyzed to assess the incidence of delayed IPH after treatment with the PED. RESULTS: A total of 66 patients (47 anterior circulation) with cerebral aneurysms underwent treatment with a PED between January 2008 and November 2010. Four patients experienced delayed periprocedural IPH, all after the treatment of anterior circulation aneurysms (8.5%, 4/47). The aneurysm size ranged from 5 to 21 mm. All IPHs occurred within the cerebral hemisphere, ipsilateral to the treated aneurysm, and were anatomically remote from the treated aneurysms. All procedures were uncomplicated, and patients emerged from general anesthesia at neurologic baseline. The hemorrhages became clinically evident between 1 and 6 days after the procedure. Two patients had unfavorable outcomes (mRS scores, 4 and 6). CONCLUSIONS: Delayed IPH may occur after the treatment of anterior circulation aneurysms with flow diverters. This complication does not seem to be restricted to a specific aneurysm subtype and does not seem to be related to an intraprocedural complication or solely attributable to DAT.

The pipeline flow-diverting stent for exclusion of ruptured intracranial aneurysms with difficult morphologies.

BACKGROUND: The Pipeline Embolization Device (PED) is a flow-diverting stent that may represent a new therapeutic tool for difficult-to-treat intracranial aneurysms, including those that present with subarachnoid hemorrhage (SAH). OBJECTIVE: To demonstrate the feasibility of utilizing the PED as a primary treatment for ruptured aneurysms with challenging morphologies. METHODS: Three patients with ruptured intracranial aneurysms presented with SAH. Three distinct and difficult-to-treat aneurysm morphologies were encountered: (1) a small basilar trunk pseudoaneurysm, (2) a carotid artery blister aneurysm, and (3) an A1/A2 junction-dissecting-type aneurysm. All were treated with deployment of one or more PEDs across the aneurysm. RESULTS: PEDs were successfully deployed in all 3 cases. Two patients were treated with 2 overlapping PEDs, and the third patient was treated with a single device. Aneurysm obliteration was achieved in all 3 cases with no early rehemorrhage or other clinically adverse event. CONCLUSION: Endovascular treatment with the pipeline flow-diverting stent may be a viable treatment option for otherwise difficult-to-treat aneurysm morphologies in the context of acute SAH.

Pipeline Embolization Device in Aneurysmal Subarachnoid Hemorrhage

The authors used the Pipeline device to treat 20 patients with acutely ruptured intracranial aneurysms. The most common types of aneurysms treated were blister and dysplastic/dissecting. Procedure-related morbidity/mortality overall was 15%, and 1 death directly related to the procedure occurred. Occlusion rates were 75% and 94% at 6 months and 12 months, respectively. The authors concluded that the Pipeline device offers a feasible treatment option in acute or subacute ruptured aneurysms, especially the blister type. Ruptured giant aneurysms remain challenging for both surgical and endovascular techniques; at this stage, the Pipeline device should be used with caution in this aneurysm subtype. BACKGROUND AND PURPOSE: The PED is an FDS designed for the treatment of intracranial aneurysms. Data regarding the use of this device in acute or subacute aSAH is limited to a few case reports or small series. We aimed to demonstrate the feasibility of using an FDS, the PED, for the treatment of ruptured intracranial aneurysms with challenging morphologies. MATERIALS AND METHODS: We conducted a retrospective review of all known patients treated with the PED for aSAH at 4 institutions between June 2008 and January 2012. Pertinent clinical and radiologic information was submitted by individual centers for central collation. The decision to treat with the PED was made on a case-by-case basis by a multidisciplinary team under compassionate use. RESULTS: Twenty patients (15 women; median age, 54.5 years; IQR, 8.0 years) were found. There were 8 blister, 8 dissecting or dysplastic, 2 saccular, and 2 giant aneurysms. Median time to treatment was 4 days (range, 1–90 days; IQR, 12.75 days) from rupture. Three patients had previous failed treatment. Procedure-related symptomatic morbidity and mortality were 15%, with 1 (5%) procedure-related death. Two patients died relative to medical complications, and 1 patient was lost to follow-up. Sixteen patients were available for follow-up, 81% had a GOS of 5, and 13% had a GOS of 4 attributed to a poorer initial clinical presentation. One patient died of urosepsis at 4 months. Occlusion rates were 75% and 94% at 6 months and 12 months, respectively. There were 3 delayed complications (1 silent perforator infarct, 2 moderate asymptomatic in-stent stenoses). No symptomatic delayed complications or rehemorrhages occurred. CONCLUSIONS: The FDS may be a feasible treatment option in the acute or subacute setting of selected ruptured aneurysms, especially blister aneurysms. Ruptured giant aneurysms remain challenging for both surgical and endovascular techniques; at this stage, FDSs should be used with caution in this aneurysm subtype.

Small Pipes: Preliminary Experience with 3-mm or Smaller Pipeline Flow-Diverting Stents for Aneurysm Repair prior to Regulatory Approval

SUMMARY: Flow diversion has become an established treatment option for challenging intracranial aneurysms. The use of small devices of ≤3-mm diameter remains unapproved by major regulatory bodies. A retrospective review of patients treated with Pipeline Embolization Devices of ≤3-mm diameter at 3 Canadian institutions was conducted. Clinical and radiologic follow-up data were collected and reported. Twelve cases were treated with ≥1 Pipeline Embolization Device of ≤3-mm diameter, including 2 with adjunctive coiling, with a median follow-up of 18 months (range, 4–42 months). One patient experienced a posttreatment minor complication (8%) due to an embolic infarct. No posttreatment hemorrhage or delayed complications such as in-stent stenosis/thrombosis were observed. Radiologic occlusion was seen in 9/12 cases (75%) and near-occlusion in 2/12 cases (17%). Intracranial aneurysm treatment with small-diameter flow-diverting stents provided safe and effective aneurysm closure in this small selected sample. These devices should be further studied and considered for regulatory approval.

CT and MR imaging of non-cavernous cranial dural arteriovenous fistulas: Findings associated with cortical venous reflux

PURPOSE To compare the conventional CT and MR findings of DAVFs in relation to the venous drainage pattern on digital subtraction angiography (DSA). MATERIALS AND METHODS Cross-sectional imaging findings (CT and/or MR) in 92 patients were compared to the presence of cortical venous reflux (CVR) on DSA. RESULTS Imaging features significantly more prevalent in patients with CVR included: abnormally dilated and tortuous leptomeningeal vessels (92% vs. 4%, p<0.001) or medullary vessels (69% vs. 0%, p<0.001), venous ectasias (45% vs. 0%, p<0.001) and focal vasogenic edema (38% vs. 0%, p<0.001). The following findings trended towards association but did not reach the p value established following Bonferroni correction: dilated external carotid artery branches (71% vs. 38%, p=0.005), cluster of vessels surrounding dural venous sinus (50% vs. 19%, p=0.009), presence of hemorrhage (33 vs. 12%, p=0.040), and parenchymal enhancement (21% vs. 0%, p=0.030). CONCLUSION In the appropriate clinical setting, recognition of ancillary signs presumably related to venous arterialization and congestion as well as arterial feeder hypertrophy should prompt DSA confirmation to identify DAVFs associated with CVR.

Ophthalmic vein compression for selected benign low-flow cavernous sinus dural arteriovenous fistulas.

Dural arteriovenous fistulas (DAVFs) of the cavernous sinus are acquired arteriovenous shunts between the dural branches of the internal and external carotid arteries and the cavernous sinus. These fistulas may present with cortical venous reflux, but more commonly drain antegradely toward the superior ophthalmic vein (SOV). Transvenous embolization is the most common endovascular treatment, but in some cases transvenous access to the compartment of the shunt may not be possible. In cases with no corticovenous reflux, manual compression of the SOV is an excellent alternative treatment, which is well known but rarely reported in the literature. The authors describe a series of 3 cavernous DAVFs with anterior drainage treated successfully by intermittent manual compression of the SOV.

Comprehensive data visualization for high resolution endovascular carotid arterial wall imaging

Carotid angioplasty and stenting is a minimally invasive endovascular procedure that may benefit from in vivo high resolution imaging for monitoring the physical placement of the stent and potential complications. The purpose of this pilot study was to evaluate the ability of optical coherence tomography to construct high resolution 2D and 3D images of stenting in porcine carotid artery. Four Yorkshire pigs were anaesthetized and catheterized. A state-of-the-art optical coherence tomography (OCT) system and an automated injector were used to obtain both healthy and stented porcine carotid artery images. Data obtained were then processed for visualization. The state-of-the-art OCT system was able to capture high resolution images of both healthy and stented carotid arteries. High quality 3D images of healthy and stented carotid arteries were constructed, clearly depicting vessel wall morphological features, stent apposition and thrombus formation over the inserted stent. The results demonstrate that OCT can be used to generate high quality 3D images of carotid arterial stents for accurate diagnosis of stent apposition and complications under appropriate imaging conditions.

Carotid artery angioplasty and stenting for patients less than 70 years-of-age.

BACKGROUND Recent studies have suggested that carotid artery angioplasty and stenting (CAS) is a safe alternative to carotid endarterectomy (CEA) in average risk patients <70 years of age. We examined a consecutive series of patients who underwent CAS in order to determine the influence of patient age on outcome. METHODS A retrospective, longitudinal cohort study of consecutive patients who underwent CAS at St. Michaels Hospital, Canada between January 2001 and November 2010 was performed. The outcome measures were 30-day stroke and 30-day composite death, stroke and acute myocardial infarction (MI). Patients were stratified based on age <70 and ≥ 70 years. RESULTS One hundred and fifty-nine patients underwent 165 CAS procedures. The 30-day risk of stroke was 3.8% while the composite outcome of death/stroke/MI was 8.2%. When stratified by age <70 and ≥ 70 years, the 30-day stroke rate was 0% versus 7.4% (p=0.03), and the composite outcome of death/stroke/MI was 2.6% versus 13.6% (p=0.02), respectively. CONCLUSIONS Patients <70 years of age undergoing CAS have a low rate of major complications, comparing favourably with historical CEA adverse event rates, and supporting the recent carotid stenosis literature that in the younger population CAS has a similar complication rate compared to CEA.

Feasibility of endovascular optical coherence tomography for high-resolution carotid vessel wall imaging

Carotid Artery Stenting (CAS) is a procedure that treats carotid atherosclerosis which should be monitored by in vivo high resolution imaging for the quality of the procedure and potential complications. The purpose of this pilot study is to evaluate the ability of optical coherence tomography to construct high resolution two and three dimensional images of stenting in porcine carotid artery for high accuracy diagnostic purposes. Four Yorkshire pigs were anaesthetized and catheterized. A state-of-the-art optical coherence tomography (OCT) system (Lightlab Imaging, St. Jude Medical Inc.) and an automated injector were used to obtain both healthy and stented porcine carotid artery images. Data obtained were then processed for visualization. The state-of-the-art OCT system was able to capture high resolution images of both healthy and stented carotid arteries. High quality three dimensional images of stented carotid arteries were constructed, clearly depicting stent apposition and thrombus formation over different stents. The results demonstrated that current state-of-the-art OCT system can be used to generate high quality three dimensional images of carotid arterial stents for accurate diagnosis of stent apposition and complications under appropriate imaging conditions.

Pediatric Vascular Malformations of the Brain: Concepts and Classifications, Diagnosis and Endovascular Treatment

Pediatric brain areterio venous shunts (AVS) are relatively uncommon lesions, and have different characteristics when compared to adults. During this chapter we will review the basic concepts of brain vasculogenesis and angiogenesis, as well as the concept of the triggering event in the development of brain AVS, where an early trigger will result in more diffuse lesions, as opposed to late triggers that will explain more localized lesions. We will also discuss the differences between adult and pediatric population AVS, and why this is specially relevant for classification schemes and in developing treatment strategies. The adult-based classification AVS is particularly inappropriate in children, in whom (a) cerebral eloquence is difficult to assess because of the remodeling potential, (b) most lesions are fistulas or multifocal, (c) the drainage more commonly affects the entire venous system, and (d) the potential for recovery is different. In addition, the anatomic and physiologic characteristics of the neonatal and infant brain (including hydrovenous peculiarities and immaturity of myelination) create a specific group of nonhemorrhagic symptoms and therapeutic challenges that are not encountered in adults.